IL17A and rheumatoid arthritis: In addition, Kim et al. [23], reported that quercetin inhibited osteoclastogenesis, reduced RANKL levels, and decreased RANKL and IL-17-induced differentiation of monocytes to osteoclasts in multiple ways, and could be potentially used as an alternative therapeutic agent in regulating bone destruction and inflammation in rheumatoid arthritis.